Himanshu Savardekar

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Inhibition of Bruton’s tyrosine kinase with PD-1 blockade modulates T cell activation in solid tumors”.

Inhibition of Bruton’s tyrosine kinase with PD-1 blockade modulates T cell activation in solid tumors

JCI Insight(2024)10.1172/jci.insight.169927

N/A

0.312DataRank · unranked

6 citations

Brooke Benner, Robert Wesolowski, Dionisia Quiroga, Logan Good, Steven Sun +27 more

Effect of Immune Checkpoint Blockade on Myeloid-Derived Suppressor Cell Populations in Patients With Melanoma

Frontiers in Immunology(2021)10.3389/fimmu.2021.740890

N/A

0DataRank · unranked

38 citations

Brooke Benner, Himanshu Savardekar, Gabriella Lapurga, Logan Good, David Abood +13 more

686 Characterization of a novel compound that inhibits peroxynitrite generation by myeloid derived suppressor cells

Regular and Young Investigator Award Abstracts(2021)10.1136/jitc-2021-sitc2021.686

N/A

0DataRank · unranked

1 citations

Steven Sun, Erick J. Carlson, Himanshu Savardekar, Kari Kendra, Blake R. Peterson +2 more

A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1552

N/A

0DataRank · unranked

36 citations

Brooke Benner, Lai Wei, Vineeth Sukrithan, Ashima Goyal, Ye Zhou +17 more

BTK inhibition potentiates anti-PD-L1 treatment in murine melanoma: potential role for MDSC modulation in immunotherapy

Cancer Immunology Immunotherapy(2023)10.1007/s00262-023-03497-1

N/A

0DataRank · unranked

15 citations

Colin D. Angell, Himanshu Savardekar, Debasish Sundi, David Abood, Brooke Benner +15 more

Data from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms

(2023)10.1158/1078-0432.c.6533090

N/A

0DataRank · unranked

0 citations

Brooke Benner, Lai Wei, Vineeth Sukrithan, Ashima Goyal, Ye Zhou +17 more

Data from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms

(2023)10.1158/1078-0432.c.6533090.v1

N/A

0DataRank · unranked

0 citations

Brooke Benner, Lai Wei, Vineeth Sukrithan, Ashima Goyal, Ye Zhou +17 more

Targeting Myeloid-Derived Suppressor Cells via Dual-Antibody Fluorescent Nanodiamond Conjugate

Nanomaterials(2024)10.3390/nano14181509

N/A

0DataRank · unranked

1 citations

Gabriella Lapurga, Steven Sun, Courtney Johnson, Himanshu Savardekar, Isaac V. Rampersaud +7 more

BRD4 inhibition leads to MDSC apoptosis and enhances checkpoint blockade therapy

Journal of Clinical Investigation(2025)10.1172/jci181975

N/A

0DataRank · unranked

6 citations

Andrew Stiff, Alvin Liu, Robert Wesolowski, Emily Schwarz, Ian C. Garbarine +23 more

PRMT5-Selective Inhibitors Suppress Inflammatory T Cell Responses and Experimental Autoimmune Encephalomyelitis

UNC Libraries(2020)10.17615/epph-ze52

N/A

0DataRank · unranked

0 citations

Lindsay Webb, Mireia Guerau-De-Arellano, Stephanie A. Amici, Vrajesh Karkhanis, Chenglong Li +10 more

A comparison of myeloid-derived suppressor cell populations in patients with ulcerated vs non-ulcerated melanoma receiving immune checkpoint blockade

Melanoma Research(2025)10.1097/cmr.0000000000001023

N/A

0DataRank · unranked

0 citations

Steven Sun, Gabriella Lapurga, Brooke Benner, Dionisia Quiroga, Himanshu Savardekar +11 more